52 results about "Mucous gland" patented technology

A device and method for treating bodily conduits involves the application of energy to the smooth muscle tissue of the conduit walls to reduce the bulk of smooth muscle tissue and mucus glands. The irradiation treatment of the smooth muscle tissue causes a reduction in the amount of smooth muscle tissue over time which increases the inner diameter of the body conduit for improved fluid flow and prevents smooth muscle spasms. The treatment is particularly useful in the lungs for treatment of asthma to prevent bronchospasms, increase the airway diameter for improved air exchange, and reduce mucus secretions in the lungs.

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises rhizoma polygonati, threonine, serine, cysteine and cystine. Rhizoma polygonati has the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises glossy ganoderma, rhizoma bistortae, threonine, serine, cysteine and cystine. Glossy ganoderma and rhizoma bistortae have the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.

The invention discloses a combination formula for regulating surface mucus layer barriers of a digestive duct and a respiratory tract and belongs to the field of medicines. The combination formula comprises Wolfiporia extensa, threonine, serine, cysteine, cysteine and proline, wherein the Wolfiporia extensa has the effect of enhancing blood supply and oxygen supply; threonine, serine, cysteine and proline are main constituents of mucoproteins. The combination formula provides nutrition, oxygen and raw materials for generation, regeneration, repair and mucoprotein of mucous glands and mucilage cells such as goblet cells and the like of the digestive duct and the respiratory tract; the combination formula is an effective combination formula for constructing normal surface mucus layer barriers of the digestive duct and the respiratory tract of a human body, preventing antigens from getting close to, being contacted with, adhering to and entering the digestive duct and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing the digestive duct and respiratory tract tissue and preventing and treating diseases of a digestive system and a respiratory system.

The invention belongs to the technical field of preparation of animal bioreactors, and particularly relates to a preparation method of a fish skin mucous gland bioreactor and an application of the preparation method. The preparation method comprises the steps of identifying specific expression genes, promoters and protein secreting signal peptide of fish skin mucous gland cells, constructing transgene expression vectors which can specifically express endogenous or heterogenesis bioactive substances in fish skin and mucous gland cells, and developing transgenic fish which can stably inherit andsecrete bioactive substances to fish mucosa, wherein the bioactive substances secreted by mucous glands can be used for growth, stress resistance and disease resistance of animals and plants, healthcare and disease prevention and treatment of human, and enzymes for business. The developed fish skin mucous gland bioreactor disclosed by the invention has the characteristics that breeding and groupextending are easy, much skin mucus secretes, mucus collection is convenient, and the bioactive substances are easy to purify, and large-scale production and high-efficiency application of the fish skin mucous gland bioreactor can be realized.

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises chuanxiong rhizomes, threonine, serine, cysteine and cystine. Chuanxiong rhizomes have the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.